- Drug giant announced results on Friday
- Study on 775 COVID patients found pill reduced hospitalization and death rates by 89 per cent compared to patients giving a dummy pill
- Results of independent study were so impressive Pfizer halted it early to seek approval for its usage
- It wants the Food and Drug Administration to authorize the treatment ASAP
- Rival manufacturer Merck’s COVID pill is already under consideration by FDA
Pfizer Inc announced on Friday that its experimental pill to treat COVID-19 can cut rates of hospitalization and death by nearly 90 percent.
The New York-based pharmaceutical company said it is no longer taking new patients in a clinical trial of the drug ‘due to the overwhelming efficacy’ and plans to submit data to U.S. regulators soon.
‘We were hoping that we had something extraordinary, but it’s rare that you see great drugs come through with almost 90 percent efficacy and 100 percent protection for death,’ Dr Mikael Dolsten, Pfizer’s chief scientific officer, said in an interview.
This is the second pill to prove effective at treating the disease after Merck & Co announced last month that its experimental antiviral could reduce the risk of serious illness and death by half.
Pfizer’s candidate, which is called PF-07321332, belongs to a class of drugs known as protease inhibitors.
The pill would work by inhibiting an enzyme that the coronavirus uses to make copies of itself inside human cells.
Protease inhibitors have been effective at treating other viral pathogens such as HIV and hepatitis C virus, both on their own and in combination with other antivirals, the company said.
Pfizer believes this class of molecules may provide well-tolerated treatments against COVID-19, as currently marketed therapeutics that work on the same lines have not reported safety concerns.
On Friday, the drugmaker released preliminary results of its study of 775 adults who contracted mild-to-moderate COVID-19.
All were unvaccinated and were considered high risk for hospitalization due to health problems such as obesity, diabetes or heart disease.
Treatment began within three to five days of initial symptoms, and lasted for five days….
News
Nasal Alzheimer’s Vaccine To Start Human Trials for the First Time
Brigham and Women's Hospital in Boston Massachusetts will soon begin Phase I trials of a nasal vaccine designed to prevent or slow the progression of Alzheimer's disease (AD), a press release said. This is the [...]
Innovations in Nanocomposites: A Future Outlook
Nanocomposites are a class of nanomaterials, where one or more nanostructured materials (organic/inorganic) are incorporated in metal, polymer, or ceramic to obtain a new material with many unique properties. Nanocomposites are applied in various [...]
Pfizer – updated version of vaccine ‘ready in 100 days’ if the new Omicron resistant to its current vaccine
Pfizer said it will be able to manufacture and distribute an updated version of its COVID-19 vaccine within 100 days if the new variant Omicron is found to be resistant to its current vaccine. [...]
B.1.1.529 – What do we know about the new ‘worst ever’ Covid variant?
UK places South Africa on red travel list over B.1.1.529 variant picked up by scientists in country. What is the new variant and why is it a concern? Scientists have detected a new Covid-19 [...]
Scientists warn of new Covid variant with high number of mutations
The B.1.1.529 variant was first spotted in Botswana and six cases have been found in South Africa. Scientists have said a new Covid variant that carries an “extremely high number” of mutations may drive [...]
New microscope uses photonics to gain insights into superbugs
Scientists are building a new super-resolution microscope that uses laser light to study the inner workings and behaviours of superbugs to gain new insights into how they cause disease. The microscope will allow scientists [...]
Researchers make ultra-sensitive cancer detector from 2D materials
Cells can produce unique electrical signals. These signals can be linked to various cancers, such as the breast, lung, liver, brain, pancreas and prostate cancers, meaning that they can be used as indicators for [...]
New sensor detects ever smaller nanoparticles
Conventional microscopes produce enlarged images of small structures or objects with the help of light. Nanoparticles, however, are so small that they hardly absorb or scatter light and, hence, remain invisible. Optical resonators increase [...]
How Will the COVID Pills Change the Pandemic?
From a new article By Dhruv Khullar in the New York Times: New antiviral drugs are startlingly effective against the coronavirus—if they’re taken in time. n March, 2020, researchers at Emory University published a paper about a [...]
Is Delta the last Covid ‘super variant’?
Every week, a group of epidemiologists across the north-east of the United States joins a Zoom call entirely devoted to discussing the latest hints of new Covid-19 variants being reported around the world. “It’s like the [...]
Cancer cells use ‘tiny tentacles’ to suppress the immune system
To grow and spread, cancer cells must evade the immune system. Investigators from Brigham and Women's Hospital and MIT used the power of nanotechnology to discover a new way that cancer can disarm its [...]
Cancer cells use ‘tiny tentacles’ to suppress the immune system
To grow and spread, cancer cells must evade the immune system. Investigators from Brigham and Women's Hospital and MIT used the power of nanotechnology to discover a new way that cancer can disarm its [...]
3D printing approaches atomic dimensions
A new 3D printing technology makes the production of complex metallic objects at the nanoscale possible. A team of chemists led by a scientist from the University of Oldenburg has developed an electrochemical technique [...]
Nanoscale ‘computer’ controls function of protein, influences cell behavior
The creation of nanoscale computers for use in precision health care has long been a dream of many scientists and health care providers. Now, for the first time, researchers at Penn State have produced [...]
Could liposomes be the unsung heroes of the pandemic?
Liposomes may be the unsung heroes of the COVID-19 pandemic. Without the protection of these microscopic vesicles, the delicate strands of messenger RNA (mRNA) that lie at the heart of the Pfizer and Moderna [...]
Pfizer agrees to let other companies make its COVID-19 pill
London: Drugmaker Pfizer has signed a deal with a UN-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the [...]
